The National Agency for Food and Drugs Administration and Control (NAFDAC) has raised the alarm over the circulation of suspected counterfeit Augmentin six hundred and twenty-five (625) milligrams tablets in the country.
The alert paper was signed by the management of NAFDAC and titled ‘NAFDAC Alert and Sensitization of The Public On Suspected Falsified Augmentin 625mg’ and published on the agency’s website.
According to NAFDAC, the product fell short of the labeling requirements and hinted that the suspected falsified Augmentin which was manufactured in April 2021 would expire in April 2024.
It also noted that the batch number of the falsified drug is 562626 with a NAFDAC registration number- 04-1928.
Uploaded By: OLUWASEYI OLORUNLEKE
Join our twitter community :